These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20409426)

  • 1. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence.
    Simon SL; Dean AC; Cordova X; Monterosso JR; London ED
    J Stud Alcohol Drugs; 2010 May; 71(3):335-44. PubMed ID: 20409426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.
    Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I;
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
    Kalechstein AD; Newton TF; Green M
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):215-20. PubMed ID: 12724464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological deficits in adolescent methamphetamine abusers.
    King G; Alicata D; Cloak C; Chang L
    Psychopharmacology (Berl); 2010 Oct; 212(2):243-9. PubMed ID: 20640405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.
    Basterfield C; Hester R; Bowden SC
    Neuropsychology; 2019 Jul; 33(5):739-753. PubMed ID: 31021107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.
    Zhong N; Jiang H; Du J; Zhao Y; Sun H; Xu D; Li C; Zhuang W; Li X; Hashimoto K; Zhao M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():31-7. PubMed ID: 27085943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans.
    Dean AC; Sevak RJ; Monterosso JR; Hellemann G; Sugar CA; London ED
    J Stud Alcohol Drugs; 2011 Nov; 72(6):943-53. PubMed ID: 22051208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls.
    Wang LJ; Chen CK; Lin SK; Chen YC; Xu K; Huang MC
    Psychopharmacology (Berl); 2018 Jul; 235(7):2113-2121. PubMed ID: 29713787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory impairment in methamphetamine dependent patients.
    Moon M; Do KS; Park J; Kim D
    Int J Neurosci; 2007 Jan; 117(1):1-9. PubMed ID: 17365096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive function in methamphetamine users with and without psychosis.
    Koopowitz SM; Cotton SM; Uhlmann A; Thomas KGF; Stein DJ
    Psychiatry Res; 2022 Nov; 317():114820. PubMed ID: 36075151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
    Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug abstinence and cognitive control in methamphetamine-dependent individuals.
    Salo R; Nordahl TE; Galloway GP; Moore CD; Waters C; Leamon MH
    J Subst Abuse Treat; 2009 Oct; 37(3):292-7. PubMed ID: 19339145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.
    Stock AK; Rädle M; Beste C
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():41-52. PubMed ID: 29953935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
    Hester R; Lee N; Pennay A; Nielsen S; Ferris J
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers.
    Hosak L; Preiss M; Bazant J; Tibenska A; Cermakova R; Cermakova E
    Psychiatr Danub; 2012 Jun; 24(2):188-93. PubMed ID: 22706418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence.
    Proebstl L; Krause D; Kamp F; Hager L; Manz K; Schacht-Jablonowsky M; Straif M; Riebschläger M; Neumann S; Schreiber A; Soyka M; Koller G
    Psychiatry Res; 2019 Nov; 281():112599. PubMed ID: 31629302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of relapse on cognition in abstinent methamphetamine abusers.
    Simon SL; Dacey J; Glynn S; Rawson R; Ling W
    J Subst Abuse Treat; 2004 Jul; 27(1):59-66. PubMed ID: 15223095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
    Chen YC; Wang LJ; Lin SK; Chen CK
    Subst Use Misuse; 2015; 50(14):1778-85. PubMed ID: 26625283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition during active methamphetamine use versus remission.
    Huckans M; Boyd S; Moncrief G; Hantke N; Winters B; Shirley K; Sano E; McCready H; Dennis L; Kohno M; Hoffman W; Loftis JM
    J Clin Exp Neuropsychol; 2021 Aug; 43(6):599-610. PubMed ID: 34612792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.